CTL Lab Belgium
ActiveSummary
The computed 12-month bankruptcy probability of CTL Lab Belgium is 1.6% (moderate). The 2024 annual accounts show equity of €300k and a net result of €64k. Equity is growing by ~26.1% per year across the filed fiscal years. Its solvency ranks better than 39% of 6537 sector peers (fiscal year 2024). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
52
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability75▲+13
Solvency49▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
1.6%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €15k at 30 days acceptable
Liquidity tight (current ratio 1.31 against 1.24 in 2023; short-term debt: 75.9% and cash: 3.4% of total assets), and 76.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
20 d late
2022
31 d early
2021
31 d late
2020
82 d late
2019
122 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€64k▼ 37.8%
2023 · €103k
2018: €41k
2019: €86k
2020: €27k
2021: €119k
2022: €70k
2023: €103k
2018 → 2024
Working capital
€296k▲ 31.8%
2023 · €225k
2018: €-6k
2019: €83k
2020: €112k
2021: €168k
2022: €180k
2023: €225k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€124k-€183k▲ 47.9%€193k▲ 5.5%€236k▲ 22.3%€300k▲ 27.1%
Operating result€40k-€123k▲ 207%€57k▼ 54.0%€124k▲ 119%€64k▼ 48.7%
Net result€27k-€119k▲ 335%€70k▼ 41.2%€103k▲ 46.9%€64k▼ 37.8%
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 49% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.26M
Fixed assets
€7k ▼ 42.9%
Current assets
€1.25M ▲ 9.2%
Equity and liabilities €1.26M
Equity
€300k ▲ 27.1%
Debt
€959k ▲ 4.0%
Debt's share of the balance-sheet total falls from 79.6% to 76.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€66k▼
2023 · €126k
Cash flow
€66k▼
2023 · €105k
Current ratio
1.31▲
2023 · 1.24
Debt to equity
3.19▼
2023 · 3.90
ROE
21.3%▼
2023 · 43.6%
ROA
5.1%▼
2023 · 8.9%
Interest coverage
7.25▲
2023 · 3.90
Debt ≤ 1 year
€957k▲
2023 · €922k
Income taxes
€47k▲
2023 · €32k
Staff costs
€196k▲
2023 · €164k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 48 lines
Balance sheet
Code20232024
Assets
Total assets20/58€1.16M€1.26M▲
Fixed assets21/28€12k€7k▼
Intangible fixed assets21€6k€4k▼
Financial fixed assets28€6k€3k▼
Current assets29/58€1.15M€1.25M▲
Amounts receivable within one year40/41€1.12M€1.21M▲
Trade receivables40€236k€242k▲
Other amounts receivable41€884k€968k▲
Cash at bank and in hand54/58€27k€43k▲
Deferred charges and accrued income490/1€65-
Equity and liabilities
Total equity and liabilities10/49€1.16M€1.26M▲
Equity10/15€236k€300k▲
Contributions10/11€6k€6k=
Reserves13€2k€66k▲
Distributable reserves133€2k€66k▲
Profit (loss) carried forward14€228k€228k=
Amounts payable17/49€922k€959k▲
Amounts payable within one year42/48€922k€957k▲
Financial debts43€2k€3k▲
Credit institutions430/8€2k€3k▲
Trade debts44€298k€426k▲
Suppliers440/4€298k€426k▲
Advances received on contracts in progress46€16k€16k=
Taxes, remuneration and social security45€547k€512k▼
Taxes450/3€499k€432k▼
Remuneration and social security454/9€48k€80k▲
Other amounts payable47/48€60k-
Accrued charges and deferred income492/3€233€3k▲
Income statement
Code20232024
Remuneration, social security and pensions62€164k€196k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€2k=
Other operating charges640/8€24k€8k▼
Gross operating margin9900€314k€269k▼
Operating profit (loss)9901€124k€64k▼
Financial income75/76B€43k€56k▲
Recurring financial income75€43k€56k▲
Financial charges65/66B€32k€9k▼
Recurring financial charges65€32k€9k▼
Profit (loss) for the period before taxes9903€135k€111k▼
Income taxes67/77€32k€47k▲
Profit (loss) for the period9904€103k€64k▼
Profit (loss) for the period to be appropriated9905€103k€64k▼
Appropriation of the result
Profit (loss) to be appropriated9906€288k€292k▲
Profit (loss) brought forward from the previous period14P€185k€228k▲
Transfer to equity691/2-€64k
To other reserves6921-€64k
Profit to be distributed694/7€60k-
Directors or managers695€60k-
Social balance
Average headcount (FTE)90872.02.0=
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 61 days late
2024
20-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 20 days late
2023
31-12
Financial
Equity above €200kEq €236k ▲22.3%
6 profitable years in a row build equity to €236k.
30-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Highest result since 2018net €119k ▲335%
Net result €119k, the highest in the series.
31-12
Financial
Equity above €150kEq €183k ▲47.9%
4 profitable years in a row build equity to €183k.
21-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 82 days late
2020
31-12
Financial
Weakest financial yearnet €27k ▼68.2%
Net result drops to €27k, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €100kEq €124k ▲28.5%
3 profitable years in a row build equity to €124k.
30-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 122 days late
2019
29-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 29 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2016
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Maria Malibranstraat 401050 ElseneGround area
7,617 m²
Building footprint
1,095 m²
Volume, LiDAR
32,559 m³
2 parcels, Brussels · tallest building 37.2 m, ±11 floors. Linked by address, not a title deed.
1 establishment unit
CTL Lab Belgium
since 20162.258.836.030
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21652E0041/00D002 | Brussels | 7,508 m² | 1 · 1,001 m² | 37.2 m · 11 fl. |
| 21442A0121/00S008 | Brussels | 108 m² | 1 · 95 m² | 17.2 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Public money · subsidies and aid
Flemish government
2024 to 2025 · 2 entries · 31,539 EUR awarded · 31,539 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 17,841 EUR | 17,841 EUR |
| 2024 | 1 | 13,698 EUR | 13,698 EUR |
Schemes
Individueel Maatwerk
Similar companies · same sector, comparable size
APOTHEEK DE PRETER A.
BE 0474.850.137
Sint-Niklaas · Eq €301k
MEDISERVE
BE 0476.862.292
Ninove · Eq €300k
HOORATELIER
BE 0847.576.595
Duffel · Eq €302k
LEANOR
BE 0751.569.658
Beringen · Eq €299k
CENTRE AUDITIF - MONS
BE 0462.433.741
Mons · Eq €303k
Of 1,070 companies in sector 47741 we hold annual accounts for 644. 476 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded25-11-2016
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.